Ongoing study - RSV infections constitute a public health problem affecting vulnerable populations, such as infants, especially premature infants, older adults, and immunocompromised people. This research project aims to analyse the risk-benefit balance of vaccination of the elderly and passive immunisation of infants (by vaccination of pregnant women or injection of monoclonal antibodies into infants after birth). In this rapidly evolving field, the project is based on a rolling review of the literature. The results are primarily intended to feed into the advisory reports of the NITAG (Superior Health Council).
Published reviews
|
Advisory reports of the NITAG (Superior Health Council) |
SEE ALSO
- Study 2018-15 (HSR) Shifting care from inpatient towards day-care and ambulatory care: impact on readmission rates & post-discharge mortality
- Study 2020-01 (HTA) Assessment of a mobile application in the rehabilitation of patients undergoing primary knee or hip arthroplasty
- Study 2023-06 (HSR) How to improve the access to supportive care for children with life-threatening or life-limiting diseases and their family?
- Study 2023-53 (HSR) Evaluation of the pilot project to implement the New Deal model.
- Study 2023-60 (collaboration): Clinical effectiveness and safety of immunisation against respiratory syncytial virus (RSV)
CONTACT
ANNUAL REPORT
